Early access
Sign in
Taking people in SwitzerlandNo phase

Swiss registry following people with diabetes across Switzerland over time

Collects health data from adults with diabetes treated at Swiss study centers.

Key facts

Who runs it
Insel Gruppe AG, University Hospital Bern
Where
Bern, Lausanne, Sankt Gallen, and Zurich, SwitzerlandSee the 4 sites
Trial code
Registry title
Swiss Diabetes Registry - SwissDiab Study
Status
Recruiting
People taking part
1,500 people, planned
Started
Jan 2010
Expected to end
Jan 2099
Type of study
Observational
Record updated
11 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with diabetes who are regularly seen and treated at the study centers in Switzerland, whatever type of diabetes they have.

Age
Older than 18 years.
Sex
All sexes can join.
Disease stage
Diabetes mellitus diagnosed according to ADA criteria. Any type, any duration.

Main reasons for not taking part

  • Gestational diabetes
  • Unable to give informed consent
  • Legally incompetent or unable to follow the study terms and conditions
  • Life expectancy clearly shortened, less than 1 year

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Age > 18 years
  • Diagnosis of diabetes mellitus according to ADA criteria
  • Informed consent

Who cannot take part

  • Patients with gestational diabetes mellitus, patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions as well as patients with significantly reduced life expectancy (<1 year) will be excluded

Where in Switzerland

  • Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital BernBern, SwitzerlandContact: Markus Laimer, PD Dr. med.Taking people
  • Service d'endocrinologie, diabétologie et métabolismeLausanne, SwitzerlandContact: Valerie SchwitzgebelTaking people
  • Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen, Kantonsspital St.GallenSankt Gallen, SwitzerlandContact: Michael Brändle, Prof. Dr. med., M.Sc. (principal investigator)Taking people
  • Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital ZürichZurich, SwitzerlandContact: Roger Lehmann, Prof. Dr. med. (principal investigator)Taking people

About the trial

What the trial wants to find out

Currently, the estimated number of people with diabetes mellitus is approximately 387 million people worldwide. Due to population growth, urbanization, ageing and the rising prevalence of obesity the numbers of individuals with diabetes is increasing likewise. It has been shown that improving glycemic control is associated with a reduction in late complications of diabetes, such as cardiovascular and microvascular diseases. Therefore, treatment guidelines were established internationally by large and renowned associations and adopted by many countries.

Read full original descriptionShow less

For Switzerland only sparse data exist on the actual implementation of such recommendations and on patient's well-being. The Swiss Diabetes Registry - SwissDiab Study is a prospective cohort study aiming at including and collecting data of virtually all patients regularly seen and treated at the study centers (≈ 500 patients each), irrespective of type, duration of diabetes or treatment . This allows the evaluation of diabetes treatment strategies at these centers. Furthermore, risk indicators for micro- and macrovascular complications, mortality as well as costs and quality of life will be assessed. Data will be recorded through an internet-based, electronic database specifically designed for this study. At a later perspective it is planned to extend data collection to general practitioner/family doctor networks in order to include a larger and more representative sample of patients with diabetes in Switzerland.

The group in the trial

  • 1

    Patients with type 1 or type 2 diabetes mellitus, monogenetic diabetes, pancreatogenic diabetes, drug-induced diabetes, other forms

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Swiss Diabetes Registry - SwissDiab Study, a Prospective Cohort Study of Patients With Diabetes in Switzerland
Plain-language title
Swiss registry following people with diabetes across Switzerland over timeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
11 June 2026